Displaying drugs 15001 - 15025 of 15220 in total
Fazadinium bromide
Experimental
(3,4-Dihydroxy-Phenyl)-Triphenyl-Arsonium
Experimental
Immucillin-G
Experimental
CRx-401
CRx-401 is a novel insulin sensitizer designed to provide anti-diabetic activity without promoting weight gain. It consists of a low dose of the analgesic diflunisal in conjunction with a modified-release therapeutic dose of bezafibrate, an anti-cholesterol agent. In third-party clinical studies, the dose of bezafibrate contained in CRx-401 has been...
Investigational
Matched Description: … lipid profiles, and this dose has proven to be well tolerated in clinical trials. ... in CRx-401 has been observed to have a positive impact on cellular pathways that influence glycemic and …
CRA-9334
Experimental
Alphamethadol
Experimental
Illicit
3-Amino-4-Oxybenzyl-2-Butanone
Experimental
Phenylacetaldehyde
Experimental
Benzylamine
Experimental
1,3-Dinitrobenzene
Experimental
Para-Bromobenzyl Alcohol
Experimental
4-Fluorobenzylamine
Experimental
3-Iodo-Benzyl Alcohol
Experimental
4-(trifluoromethyl)phenol
Experimental
2-Iodobenzylthio Group
Experimental
Displaying drugs 15001 - 15025 of 15220 in total